Fyn Phosphorylates Transglutaminase 2 (Tgm2) and Modulates Autophagy and p53 Expression in the Development of Diabetic Kidney Disease
暂无分享,去创建一个
S. Okada | M. Yamada | A. Maeshima | Kazuhiko Horiguchi | Eijiro Yamada | H. Ikeuchi | C. Bastie | R. Uehara
[1] H. Tatsukawa,et al. Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis , 2021, Cells.
[2] H. Ding,et al. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease. , 2020, The Journal of clinical investigation.
[3] Z. Dong,et al. Autophagy in kidney homeostasis and disease , 2020, Nature Reviews Nephrology.
[4] S. Oh,et al. Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma , 2020, Cells.
[5] Md Jamal Uddin,et al. Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury , 2020, Biomolecules & therapeutics.
[6] Linghong Huang,et al. Insights on the heparan sulphate-dependent externalisation of transglutaminase-2 (TG2) in glucose-stimulated proximal-like tubular epithelial cells. , 2020, Analytical biochemistry.
[7] K. Gomes,et al. Anti-inflammatory effects of C-peptide on kidney of type 1 diabetes mellitus animal model , 2019, Molecular Biology Reports.
[8] Anna E Argento,et al. FYN tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates anti-glioma immune responses , 2019, bioRxiv.
[9] Chao-Yung Wang,et al. Autophagy in Chronic Kidney Diseases , 2019, Cells.
[10] Kyung Lee,et al. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury. , 2018, Kidney international.
[11] Yue Wang,et al. Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease , 2018, Journal of Translational Medicine.
[12] Y. Isaka,et al. High-Fat Diet-Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Lipotoxicity in the Kidney. , 2017, Journal of the American Society of Nephrology : JASN.
[13] J. Hughes,et al. Renal Aging: Causes and Consequences. , 2017, Journal of the American Society of Nephrology : JASN.
[14] Yu Zhang,et al. Beclin-1- mediated autophagy may be involved in the elderly cognitive and affective disorders in streptozotocin-induced diabetic mice , 2016, Translational Neurodegeneration.
[15] E. Tremoli,et al. Inhibition of transglutaminase 2 reduces efferocytosis in human macrophages: Role of CD14 and SR-AI receptors. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[16] K. Utsunomiya,et al. Signaling pathways in diabetic nephropathy. , 2016, Histology and histopathology.
[17] S. Zhuang,et al. Autophagy in Chronic Kidney Diseases , 2016, Kidney Diseases.
[18] B. Bay,et al. Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation , 2016, eLife.
[19] D. Hong,et al. Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy , 2016, Cell Death and Disease.
[20] B. Furman,et al. Streptozotocin‐Induced Diabetic Models in Mice and Rats , 2015, Current protocols in pharmacology.
[21] Z. Dong,et al. Tubular p53 regulates multiple genes to mediate AKI. , 2014, Journal of the American Society of Nephrology : JASN.
[22] Myung-Shik Lee,et al. Autophagy—a key player in cellular and body metabolism , 2014, Nature Reviews Endocrinology.
[23] H. Kwon,et al. Fyn Deficiency Promotes a Preferential Increase in Subcutaneous Adipose Tissue Mass and Decreased Visceral Adipose Tissue Inflammation , 2013, Diabetes.
[24] A. Cuervo,et al. Mouse skeletal muscle fiber-type-specific macroautophagy and muscle wasting are regulated by a Fyn/STAT3/Vps34 signaling pathway. , 2012, Cell reports.
[25] Sangeeta Khare,et al. Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition) , 2016 .
[26] G. Johnson,et al. Transglutaminase 2 and its role in pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[27] Y. Isaka,et al. The protective role of autophagy against aging and acute ischemic injury in kidney proximal tubular cells , 2011, Autophagy.
[28] M. Komatsu,et al. Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder—murine Pompe disease , 2010, Autophagy.
[29] A. Ballabio,et al. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition , 2010, Nature Cell Biology.
[30] J. Pessin,et al. Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1. , 2010, Cell metabolism.
[31] C. Alpers,et al. Mouse models of diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.
[32] G. Melino,et al. Transglutaminase 2 is involved in autophagosome maturation , 2009, Autophagy.
[33] M. Czaja,et al. Autophagy regulates adipose mass and differentiation in mice. , 2009, The Journal of clinical investigation.
[34] M. Czaja,et al. Autophagy regulates lipid metabolism , 2009, Nature.
[35] Kun Wook Chung,et al. Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. , 2008, Cell metabolism.
[36] Masaaki Komatsu,et al. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. , 2008, Cell metabolism.
[37] J. Pessin,et al. Integrative metabolic regulation of peripheral tissue fatty acid oxidation by the SRC kinase family member Fyn. , 2007, Cell metabolism.
[38] M. Rossmeisl,et al. Variation in type 2 diabetes--related traits in mouse strains susceptible to diet-induced obesity. , 2003, Diabetes.
[39] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[40] S. Scherer,et al. X‐linked vacuolar myopathies: Two separate loci and refined genetic mapping , 2000, Annals of neurology.
[41] Ronit Vogt Sionov,et al. The cellular response to p53: the decision between life and death , 1999, Oncogene.
[42] A. Engin. What Is Lipotoxicity? , 2017, Advances in experimental medicine and biology.
[43] Yunchao Su,et al. Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6. , 2017, Kidney international.
[44] C. Greenberg,et al. TGM2 and implications for human disease: role of alternative splicing. , 2013, Frontiers in bioscience.
[45] R. Zager,et al. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. , 1994, Kidney international.